Bone Biologics Corp. -CW26BBLGWPreferred / convertible
13F holders, Q4 2024 (December 31)2holders
0new positions
0sold out
1famous investor
$42.50avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Bone Biologics Corp. -CW26 (BBLGW) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($1.5M) and UBS Group AG ($2K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bone Biologics Corp. -CW26
- CUSIP
- 098070154
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 1,996 shares sold, net −1,996 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Citadel Advisors | — | Reduce -5.4% | 34,755 | $1.5M |
| UBS Group AG | — | No change | 40 | $2K |
"% of holder's portfolio" is BBLGW's weight in each manager's 13F, not the share of Bone Biologics Corp. -CW26 the manager owns.